FTC sues Hims & Hers over misleading charges and privacy issues, causing stock to drop nearly 15%.

The Federal Trade Commission, along with California and Utah consumer protection agencies, sued Hims & Hers Health, Inc. for allegedly charging customers immediately after intake forms without clear disclosure and making subscription cancellations difficult. The FTC also claims the company misled consumers about privacy by sharing health data with third parties like Meta and Snap. Following the lawsuit announcement, Hims & Hers stock fell 14.73% to $25.00 per share. Investors and those affected are encouraged to contact Kaplan Fox & Kilsheimer LLP, which is investigating potential securities violations related to these allegations.